首页> 外国专利> 3-Hydroxy-ethyl 1,3,4,5-tetra:hydro 1,3-benzodiazepine-2-thione(s) - and related cpds. are antidepressants, intermediate 2-amino-phenyl-ethyl-amino-ethanol derivs. are also new

3-Hydroxy-ethyl 1,3,4,5-tetra:hydro 1,3-benzodiazepine-2-thione(s) - and related cpds. are antidepressants, intermediate 2-amino-phenyl-ethyl-amino-ethanol derivs. are also new

机译:3-羟基乙基1,3,4,5-四:氢1,3-苯并二氮杂-2-硫酮-和相关的cpds。是抗抑郁药,是2-氨基-苯基-乙基-氨基-乙醇的中间体。也是新的

摘要

X1,X2 substd. 3-CHR1-CHR2-(CH2)n-O-A -S-R-1,3,4,5-tetrahydro-1, 3-benzo diazepine-2-thiones of formula (I) are new (where X1,X2 are H, halo or lower alkoxy; R is H, lower alkyl or phenyl; one of R1 and R2 is H, the other is H, lower alkyl or phenyl; A is H, lower alkyl or tetrahydropyranyl; and n is 0 or 1. "Lower" implies 1-6C, opt. branched). CNS active cpds. used to treat depressive states and psychic troubles. Reserpene antagonism and S-HTP potentiator tests are described. (I) may be used as antidepressants by oral administration in daily doses of 0.05-100 mg. Activity tests compare the cpds. with imipramine and amitriptyline and LD50 of tests cpds. is over 3200 mg/kg.
机译:X1,X2替代式(I)的3-CHR1-CHR2-(CH2)nOA-SR-1,3,4,5-四氢-1,3-苯并二氮杂-2-硫酮是新的(其中X1,X2是H,卤素或低级烷氧基; R为H,低级烷基或苯基; R1和R2之一为H,另一个为H,低级烷基或苯基; A为H,低级烷基或四氢吡喃基; n为0或1。 1-6C,最佳分支)。 CNS活动cpds。用于治疗抑郁症和精神疾病。描述了对萜的拮抗作用和S-HTP增强剂测试。 (I)可以通过口服以每天0.05-100mg的剂量用作抗抑郁药。活动测试比较cpds。用丙咪嗪和阿米替林测定cpds的LD50。超过3200 mg / kg。

著录项

  • 公开/公告号FR2518544B1

    专利类型

  • 公开/公告日1984-02-10

    原文格式PDF

  • 申请/专利权人 LIPHA;

    申请/专利号FR19810023909

  • 发明设计人

    申请日1981-12-22

  • 分类号C07D243/04;A61K31/55;C07C91/40;C07C93/04;

  • 国家 FR

  • 入库时间 2022-08-22 08:45:34

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号